# A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Source: https://onco.cc/trials/nct06099769/  
OnCo record `nct06099769` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Enzalutamide and Mifepristone in Breast cancer, run by Memorial Sloan Kettering Cancer Center, now recruiting.

## Summary

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer is a phase 2 interventional study registered as NCT06099769 by Memorial Sloan Kettering Cancer Center, with 201 participants planned, started 2023-10-18 and due to reach its primary completion in 2027-10. Interventions recorded: Enzalutamide, Mifepristone, TPC. Conditions recorded: Metastatic Breast Cancer.

Linked to the drug Mifepristone because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06099769
- Phase: 2
- Setting: A RANDOMIZED, PHASE II STUDY OF ENZALUTAMIDE, ENZALUTAMIDE WITH MIFEPRISTONE, and TREATMENT OF PHYSICIAN'S CHOICE IN PATIENTS WITH AR+ METASTATIC TRIPLE-NEGATIVE OR ER-LOW BREAST CANCER
- Sponsor: Memorial Sloan Kettering Cancer Center
- Enrolled: 201

## Sources

- ClinicalTrials.gov NCT06099769: https://clinicaltrials.gov/study/NCT06099769

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- drugs: [Enzalutamide](https://onco.cc/drugs/enzalutamide/), [Mifepristone](https://onco.cc/drugs/mifepristone/)

---
JSON: https://onco.cc/api/v1/entities/nct06099769.json